Administration & Dosage
Routes of Administration
- Oxytocin is most commonly administered via intravenous (IV) infusion for labor induction or augmentation, carefully titrated using an infusion pump. For postpartum hemorrhage, it may be administered as an IV bolus, continuous infusion, or intramuscular (IM) injection. Intranasal oxytocin may be used to stimulate milk letdown in breastfeeding mothers.
Key Points
- IV administration is preferred for labor induction/augmentation due to precise dosage control.
- IM administration may be used for postpartum hemorrhage when IV access is not available.
Dosing Guidelines
- For labor induction: Start with 0.5-2 milliunits/minute IV, gradually increase by 1-2 milliunits/minute every 30-60 minutes until adequate contraction pattern is established.
- Maximum dose typically 20-40 milliunits/minute (varies by facility protocol).
- For postpartum hemorrhage: 10-40 units in 1000 mL IV fluid at 125-200 mL/hour, or 10 units IM.
- For cesarean delivery: 10-20 units added to IV fluids after delivery of infant.
Key Points
- Low-dose protocols are preferred to minimize adverse effects while achieving adequate contractions.
- Dosage must be individualized based on uterine response and maternal/fetal status.
Administration Technique
- Verify physician's order and patient identification.
- Prepare oxytocin in isotonic solution (normal saline or lactated Ringer's).
- Administer via infusion pump for precise control.
- Position patient in left lateral position to prevent supine hypotension.
- Monitor maternal vital signs, contraction pattern, and fetal heart rate continuously.
- Titrate according to facility protocol and maternal/fetal response.
Always use an infusion pump for oxytocin administration during labor induction or augmentation. Never administer as an IV bolus for labor induction as this can cause severe uterine hyperstimulation, fetal distress, and uterine rupture.
Nursing Considerations
Maternal Assessment
- Before initiating oxytocin, assess maternal vital signs, fetal heart rate, contraction pattern, and cervical status. Continuous monitoring is essential throughout oxytocin administration to detect early signs of complications such as uterine hyperstimulation or water intoxication.
Key Points
- Monitor vital signs every 15-30 minutes during administration.
- Assess contraction frequency, duration, and intensity.
- Evaluate fluid balance to prevent water intoxication.
Fetal Monitoring
- Continuous electronic fetal monitoring is mandatory during oxytocin administration to assess fetal well-being and detect signs of distress. Evaluate baseline fetal heart rate, variability, accelerations, and decelerations. Any abnormal patterns require immediate intervention, which may include decreasing or discontinuing oxytocin infusion.
Key Points
- Continuous electronic fetal monitoring is required during oxytocin administration.
- Assess for signs of fetal distress: late decelerations, prolonged decelerations, decreased variability.
Contraindications
- Oxytocin is contraindicated in situations where vaginal delivery is not advised, including cephalopelvic disproportion, unfavorable fetal positions, placenta previa, vasa previa, active genital herpes, prior classical uterine incision, and evidence of fetal distress where delivery is not imminent.
Key Points
- Absolute contraindications: cephalopelvic disproportion, placenta previa, vasa previa, transverse fetal lie, active genital herpes, umbilical cord prolapse.
- Relative contraindications: grand multiparity (>5 previous deliveries), overdistended uterus, previous uterine surgery.
Adverse Effects
- Maternal adverse effects include uterine hyperstimulation, uterine rupture, postpartum hemorrhage, water intoxication, hypotension, and anaphylaxis. Fetal/neonatal adverse effects include hypoxia, bradycardia, and low Apgar scores secondary to uterine hyperstimulation.
Key Points
- Most serious adverse effect is uterine hyperstimulation leading to fetal distress or uterine rupture.
- Water intoxication can occur with high doses due to oxytocin's antidiuretic effect.
If uterine hyperstimulation occurs (contractions lasting >90 seconds or >5 contractions in 10 minutes), immediately discontinue oxytocin, position patient on left side, administer oxygen, increase IV fluids, and notify provider.
Clinical Scenario
A 28-year-old G1P0 at 41 weeks gestation is admitted for labor induction with oxytocin. After 4 hours of oxytocin at 12 milliunits/minute, the nurse notes contractions occurring every 2 minutes, lasting 90 seconds, with moderate fetal heart rate decelerations following each contraction.
Appropriate nursing actions:
- Discontinue oxytocin infusion immediately
- Turn patient to left lateral position
- Increase IV fluid rate
- Administer oxygen via face mask at 10 L/min
- Notify provider of uterine hyperstimulation and fetal distress